PureTech Health plc (OTCMKTS:PTCHF) Short Interest Down 60.3% in January

PureTech Health plc (OTCMKTS:PTCHF) was the target of a large decline in short interest in January. As of January 15th, there was short interest totalling 6,000 shares, a decline of 60.3% from the December 31st total of 15,100 shares. Based on an average daily volume of 3,300 shares, the short-interest ratio is currently 1.8 days.

PureTech Health Price Performance

Shares of PTCHF remained flat at $1.66 during trading hours on Tuesday. PureTech Health has a fifty-two week low of $1.66 and a fifty-two week high of $3.00. The business has a 50-day moving average of $1.98 and a 200 day moving average of $2.01.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.